On July 1, eligible Medicare Part D beneficiaries can access GLP-1 medications — Ozempic, Wegovy, Mounjaro and Zepbound — at a $50 monthly copay through the Medicare GLP-1 Bridge program, a temporary ...
Pharmacy leaders matters most as executives from top health systems outline key priorities for the second half of 2026.
Managing a medical supply chain in low- and middle-income countries can mean navigating a landscape prone to extreme and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results